Markets

Market Nav

News Details

12/02/2026 12:40

Lincoln Pharma. Q3 net profit up 37.70% at Rs 28.60 cr

The company reported standalone net profit of Rs 28.60 crore for the quarter ended December 31, 2025 as compared to Rs 20.77 crore in the same period last year, registering a year-on-year growth of 37.70 per cent.

Net revenue of the company rose moderately by 13.49 per cent at Rs 166.32 crore in October-December quarter of this fiscal as against Rs 146.55 crore in the corresponding period last year.

During October-December quarter, operating expenses increased by 16.14 per cent to Rs 142.73 crore from Rs 122.89 crore in year ago period.

Other Income grew by 68.90 per cent at Rs 15.15 crore versus (Dec'24 Rs 8.97 crore).

Operating Profit slipped by 0.25 per cent to Rs 23.60 crore as against Rs 23.66 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 12.14 per cent in December quarter.

Interest declined by 58.90 per cent y-o-y to Rs 0.30 crore, while Taxation decreased by 22.63 per cent at Rs 6.12 crore (Dec'24 Rs 7.91 crore).